remifentanil has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, WQ; Li, C; Li, YS; Liu, KX; Wu, Y; Xu, M | 1 |
| Du, Z; Li, J; Wang, Y; Zhang, Y; Zhou, Q | 1 |
1 trial(s) available for remifentanil and Lung Injury, Acute
| Article | Year |
|---|---|
Limb remote ischemic preconditioning attenuates lung injury after pulmonary resection under propofol-remifentanil anesthesia: a randomized controlled study.
Topics: Acute Lung Injury; Aged; Analysis of Variance; Anesthesia, Intravenous; Anesthetics, Intravenous; Carcinoma, Non-Small-Cell Lung; Cytokines; Female; Humans; Inflammation; Ischemic Preconditioning; Lung; Lung Neoplasms; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pain, Postoperative; Piperidines; Propofol; Prospective Studies; Remifentanil; Respiratory Function Tests; Sample Size; Treatment Outcome | 2014 |
1 other study(ies) available for remifentanil and Lung Injury, Acute
| Article | Year |
|---|---|
Remifentanil attenuates lipopolysaccharide-induced acute lung injury by downregulating the NF-κB signaling pathway.
Topics: Acute Lung Injury; Animals; Down-Regulation; Lipopolysaccharides; Male; NF-kappa B; Piperidines; Rats; Rats, Sprague-Dawley; Remifentanil; Signal Transduction | 2014 |